These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22453641)

  • 1. Modeling the interaction of seven bisphosphonates with the hydroxyapatite(100) face.
    Chen C; Xia M; Wu L; Zhou C; Wang F
    J Mol Model; 2012 Sep; 18(9):4007-12. PubMed ID: 22453641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of bisphosphonate release using hydroxyapatite granules.
    Seshima H; Yoshinari M; Takemoto S; Hattori M; Kawada E; Inoue T; Oda Y
    J Biomed Mater Res B Appl Biomater; 2006 Aug; 78(2):215-21. PubMed ID: 16544308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of action of bisphosphonates.
    Rogers MJ; Frith JC; Luckman SP; Coxon FP; Benford HL; Mönkkönen J; Auriola S; Chilton KM; Russell RG
    Bone; 1999 May; 24(5 Suppl):73S-79S. PubMed ID: 10321934
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis, characterization and biological activity of hydroxyl-bisphosphonic analogs of bile acids.
    Bortolini O; Fantin G; Fogagnolo M; Rossetti S; Maiuolo L; Di Pompo G; Avnet S; Granchi D
    Eur J Med Chem; 2012 Jun; 52():221-9. PubMed ID: 22483634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanistic study of the interaction of water-soluble borate glass with apatite-bound heterocyclic nitrogen-containing bisphosphonates.
    Pramanik C; Sood P; Niu LN; Yuan H; Ghoshal S; Henderson W; Liu Y; Jang SS; Kumar S; Pashley DH; Tay FR
    Acta Biomater; 2016 Feb; 31():339-347. PubMed ID: 26675128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients.
    Jobke B; Milovanovic P; Amling M; Busse B
    Bone; 2014 Feb; 59():37-43. PubMed ID: 24211427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates enhance bacterial adhesion and biofilm formation on bone hydroxyapatite.
    Kos M; Junka A; Smutnicka D; Szymczyk P; Gluza K; Bartoszewicz M
    J Craniomaxillofac Surg; 2015 Jul; 43(6):863-9. PubMed ID: 26027867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticalcification and antiresorption effects of bisacylphosphonates.
    Van Gelder JM; Breuer E; Ornoy A; Schlossman A; Patlas N; Golomb G
    Bone; 1995 May; 16(5):511-20. PubMed ID: 7654466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.
    Nancollas GH; Tang R; Phipps RJ; Henneman Z; Gulde S; Wu W; Mangood A; Russell RG; Ebetino FH
    Bone; 2006 May; 38(5):617-27. PubMed ID: 16046206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemistry of bisphosphonates: from antiscaling agents to clinical therapeutics.
    Widler L; Jahnke W; Green JR
    Anticancer Agents Med Chem; 2012 Feb; 12(2):95-101. PubMed ID: 21864230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal osteoconduction and repair in and around submerged highly bisphosphonate-complexed hydroxyapatite implants in rat tibiae.
    Denissen H; Martinetti R; van Lingen A; van den Hooff A
    J Periodontol; 2000 Feb; 71(2):272-8. PubMed ID: 10711618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone-targeted pyrido[2,3-d]pyrimidin-7-ones: potent inhibitors of Src tyrosine kinase as novel antiresorptive agents.
    Vu CB; Luke GP; Kawahata N; Shakespeare WC; Wang Y; Sundaramoorthi R; Metcalf CA; Keenan TP; Pradeepan S; Corpuz E; Merry T; Bohacek RS; Dalgarno DC; Narula SS; van Schravendijk MR; Ram MK; Adams S; Liou S; Keats JA; Violette SM; Guan W; Weigele M; Sawyer TK
    Bioorg Med Chem Lett; 2003 Sep; 13(18):3071-4. PubMed ID: 12941336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between the chemistry and biological activity of the bisphosphonates.
    Ebetino FH; Hogan AM; Sun S; Tsoumpra MK; Duan X; Triffitt JT; Kwaasi AA; Dunford JE; Barnett BL; Oppermann U; Lundy MW; Boyde A; Kashemirov BA; McKenna CE; Russell RG
    Bone; 2011 Jul; 49(1):20-33. PubMed ID: 21497677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic pamidronate partially protects from glucocorticoid-induced bone loss in the mdx mouse model of Duchenne muscular dystrophy.
    Yoon SH; Chen J; Grynpas MD; Mitchell J
    Bone; 2016 Sep; 90():168-80. PubMed ID: 27373502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of bisphosphonates on the resorption cycle of isolated osteoclasts.
    Selander K; Lehenkari P; Väänänen HK
    Calcif Tissue Int; 1994 Nov; 55(5):368-75. PubMed ID: 7532540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of bone resorption by bisphosphonates: interactions between bisphosphonates, osteoclasts, and bone.
    Flanagan AM; Chambers TJ
    Calcif Tissue Int; 1991 Dec; 49(6):407-15. PubMed ID: 1840176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrogen-containing bisphosphonate mechanism of action.
    Reszka AA; Rodan GA
    Mini Rev Med Chem; 2004 Sep; 4(7):711-9. PubMed ID: 15379639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of bisphosphonates.
    Rogers MJ; Watts DJ; Russell RG
    Cancer; 1997 Oct; 80(8 Suppl):1652-60. PubMed ID: 9362432
    [No Abstract]   [Full Text] [Related]  

  • 20. Bisphosphonates: from the laboratory to the clinic and back again.
    Russell RG; Rogers MJ
    Bone; 1999 Jul; 25(1):97-106. PubMed ID: 10423031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.